{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:27:03Z","timestamp":1793698023226,"version":"4.5.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010526","name":"NHS Greater Glasgow and Clyde","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010526","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Structured preceptorship programmes may support pharmacists working towards the advanced career stage, yet evidence on feasibility remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>The aim of this study was to evaluate the feasibility of a pilot preceptorship programme for pharmacists working towards the advanced career stage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>An embedded mixed-methods pilot study was conducted in primary care practices within one territorial health board in NHS Scotland, recruiting four preceptor\u2013preceptee pairs for a 16-week preceptorship programme. Quantitative data assessed programme delivery, including joint clinical sessions, shadowing sessions and changes in preceptee-reported self-efficacy and competence from baseline to 16\u00a0weeks. Qualitative data from semi-structured interviews with preceptors, preceptees, and senior pharmacy management explored perceptions of implementation barriers and enablers. Data were analysed using the COM-B framework, which considers Capability, Opportunity, and Motivation as key influences on behaviour.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Feasibility assessment demonstrated incomplete implementation, with preceptee-reported delivery of 14 of 60 anticipated joint clinical sessions (including both preceptee led clinics and shadowing sessions) and 3 of 12 anticipated structured review meetings over the 16-week programme. Self-reported self-efficacy and competence data were collected over the study period; however, due to incomplete implementation, these data are not interpreted as evidence of programme effect. Qualitative analysis identified participants\u2019 perceptions of barriers to implementation, including competing workload priorities, lack of protected time, logistical challenges, limited stakeholder engagement, and insufficient holistic feedback (as feedback primarily focused on clinical rather than practical aspects), alongside enablers such as access to resources and the perceived value of preceptorship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The pilot preceptorship programme was not fully feasible in this professional context, highlighting important considerations for future implementation. Despite incomplete delivery, participants reported perceived changes in self-reported self-efficacy and competence; however, these findings do not provide evidence of programme effect, highlighting the need for further refinement and evaluation of preceptorship models in advanced pharmacist practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02222-z","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:17:05Z","timestamp":1789733825000},"page":"2456-2466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of a pilot preceptorship programme for pharmacists working towards the advanced career stage in Scotland: a mixed-methods study"],"prefix":"10.1007","volume":"48","author":[{"given":"Mairi-Anne","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Forsyth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris F.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Boyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2222_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1898-0","volume":"16","author":"A de Bont","year":"2016","unstructured":"de Bont A, van Exel J, Coretti S, et al. Reconfiguring health workforce: a case-based comparative study explaining the increasingly diverse professional roles in Europe. BMC Health Serv Res. 2016;16:637.","journal-title":"BMC Health Serv Res"},{"key":"2222_CR2","unstructured":"International Pharmaceutical Federation. FIP workforce transformation programme. The Netherlands: International Pharmaceutical Federation; 2019. Available at https:\/\/gpo.fip.org\/fip-workforce-transformation-programme\/. Accessed 10 Jan 2022."},{"key":"2222_CR3","unstructured":"World Health Organization. Global strategy on human resources for health: workforce 2030. Geneva: World Health Organization; 2016. Available at: https:\/\/iris.who.int\/handle\/10665\/250368. Accessed 10 Jan 2022."},{"key":"2222_CR4","volume":"10","author":"J Atkinson","year":"2022","unstructured":"Atkinson J. Advances in pharmacy practice: a look towards the future. Pharmacy (Basel). 2022;10:125.","journal-title":"Pharmacy (Basel)"},{"key":"2222_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/ijpp.12611","volume":"28","author":"I Bates","year":"2020","unstructured":"Bates I, Bader LR, Galbraith K. A global survey on trends in advanced practice and specialisation in the pharmacy workforce. Int J Pharm Pract. 2020;28:173\u201381.","journal-title":"Int J Pharm Pract"},{"key":"2222_CR6","unstructured":"Royal Pharmaceutical Society of Great Britain. RPS core advanced curriculum. London: Royal Pharmaceutical Society; 2022. Available at: https:\/\/www.rpharms.com\/development\/credentialing\/core-advanced-pharmacist-curriculum. Accessed 7 Dec 2025."},{"key":"2222_CR7","unstructured":"International Pharmaceutical Federation. FIP global advanced development framework (GADF) executive summary. The Hague: International Pharmaceutical Federation; 2019. Available from: https:\/\/www.fip.org\/gadf. Accessed 10 Jan 2024."},{"key":"2222_CR8","unstructured":"General Pharmaceutical Council. Vision 2030. London: General Pharmaceutical Council; 2020. Available at: https:\/\/www.pharmacyregulation.org\/about-us\/publications-and-insights\/vision-2030. Accessed 10 Jan 2022."},{"key":"2222_CR9","unstructured":"NHS Education for Scotland. Pharmacist Career Framework Review. Edinburgh, Scotland: NHS Education for Scotland; 2020. Available at: https:\/\/www.nes.scot.nhs.uk\/media\/vzahxc4w\/final-pharmacy-pg-framework-review_v1-1.pdf. Accessed 10 Jan 2022."},{"key":"2222_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11096-023-01585-x","volume":"45","author":"S Meilianti","year":"2023","unstructured":"Meilianti S, Galbraith K, Bader L, et al. The development and validation of a global advanced development framework for the pharmacy workforce: a four-stage multi-methods approach. Int J Clin Pharm. 2023;45:940\u201351.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12909-024-05322-4","volume":"24","author":"S Ballaram","year":"2024","unstructured":"Ballaram S, Perumal Pillay V, Suleman F. A scoping review of continuing education models and statutory requirements for pharmacists globally. BMC Med Educ. 2024;24:343.","journal-title":"BMC Med Educ"},{"key":"2222_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s11096-025-02021-y","volume":"48","author":"MA McLean","year":"2026","unstructured":"McLean MA, Forsyth P, Boyter AC. Pharmacists\u2019 views on barriers and enablers to the implementation of advanced pharmacist prescribing in Scotland: a qualitative study using normalisation process theory. Int J Clin Pharm. 2026;48:534\u201343. https:\/\/doi.org\/10.1007\/s11096-025-02021-y.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy5030038","volume":"5","author":"R Seneviratne","year":"2017","unstructured":"Seneviratne R, Bradbury H, Bourne RS. How do pharmacists develop into advanced level practitioners? Learning from the experiences of critical care pharmacists. Pharmacy (Basel). 2017;5:38. https:\/\/doi.org\/10.3390\/pharmacy5030038.","journal-title":"Pharmacy (Basel)"},{"key":"2222_CR14","volume":"24","author":"M Cleary","year":"2018","unstructured":"Cleary M, Horsfall J, Happell B, et al. Preceptorship: a review of the literature. Int J Nurs Pract. 2018;24:e12650.","journal-title":"Int J Nurs Pract"},{"issue":"7","key":"2222_CR15","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ijnurstu.2015.03.007","volume":"52","author":"D Edwards","year":"2015","unstructured":"Edwards D, Hawker C, Carrier J, et al. A systematic review of the effectiveness of strategies and interventions to improve the transition from student to newly qualified nurse. Int J Nurs Stud. 2015;52(7):1254\u201368.","journal-title":"Int J Nurs Stud"},{"key":"2222_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nedt.2017.09.011","volume":"60","author":"C Irwin","year":"2018","unstructured":"Irwin C, Bliss J, Poole K. Does preceptorship improve confidence and competence in newly qualified nurses: a systematic literature review. Nurse Educ Today. 2018;60:35\u201346.","journal-title":"Nurse Educ Today"},{"issue":"5","key":"2222_CR17","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1111\/nicc.13061","volume":"29","author":"MS Lima","year":"2024","unstructured":"Lima MS, Alzyood M. The impact of preceptorship on the newly qualified nurse and preceptors working in a critical care environment: an integrative literature review. Nurs Crit Care. 2024;29(5):1178\u201389.","journal-title":"Nurs Crit Care"},{"issue":"5","key":"2222_CR18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1007\/s11096-025-01909-z","volume":"47","author":"MA McLean","year":"2025","unstructured":"McLean MA, Forsyth P, Dunlop E, et al. Developing a pharmacist preceptorship programme to support UK advanced level practice: a consensus study. Int J Clin Pharm. 2025;47(5):1248\u201360. https:\/\/doi.org\/10.1007\/s11096-025-01909-z.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR19","unstructured":"NHS England. National preceptorship framework for nursing. London: NHS England; 2022. Available from: https:\/\/www.england.nhs.uk\/publication\/national-preceptorship-framework-for-nursing\/. Accessed 29 Jan 2026."},{"key":"2222_CR20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/ijpp\/riac070","volume":"30","author":"P Forsyth","year":"2022","unstructured":"Forsyth P, Radley A, Marra F, et al. Are UK pharmacists ready for consultant-level practice? A cross-sectional survey of self-assessed development needs. Int J Pharm Pract. 2022;30:559\u201366. https:\/\/doi.org\/10.1093\/ijpp\/riac070.","journal-title":"Int J Pharm Pract"},{"key":"2222_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-026-02150-y","author":"KL Klerk-Bos","year":"2026","unstructured":"Klerk-Bos KL, Hennus MP, Ehlert M, et al. Learning, adopting, and sustaining the pharmacist-clinician role in clinical practice: a qualitative study among early adopters in the Netherlands. Int J Clin Pharm. 2026. https:\/\/doi.org\/10.1007\/s11096-026-02150-y.","journal-title":"Int J Clin Pharm"},{"issue":"6 Pt 2","key":"2222_CR22","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1111\/1475-6773.12117","volume":"48","author":"MD Fetters","year":"2013","unstructured":"Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs: principles and practices. Health Serv Res. 2013;48(6 Pt 2):2134\u201356. https:\/\/doi.org\/10.1111\/1475-6773.12117.","journal-title":"Health Serv Res"},{"issue":"5","key":"2222_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.amepre.2009.02.002","volume":"36","author":"DJ Bowen","year":"2009","unstructured":"Bowen DJ, Kreuter M, Spring B, et al. How we design feasibility studies. Am J Prev Med. 2009;36(5):452\u20137. https:\/\/doi.org\/10.1016\/j.amepre.2009.02.002.","journal-title":"Am J Prev Med"},{"issue":"3","key":"2222_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150205","volume":"11","author":"SM Eldridge","year":"2016","unstructured":"Eldridge SM, Lancaster GA, Campbell MJ, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS ONE. 2016;11(3):e0150205. https:\/\/doi.org\/10.1371\/journal.pone.0150205.","journal-title":"PLoS ONE"},{"key":"2222_CR25","unstructured":"Imperial College London. General self-efficacy scale. Available from: https:\/\/www.imperial.ac.uk\/research-and-innovation\/education-research\/evaluation\/what-can-i-evaluate\/self-efficacy\/tools-for-assessing-self-efficacy\/general-self-efficacy-scale\/. Accessed 13 Dec 2025."},{"key":"2222_CR26","first-page":"1018","volume":"48","author":"NM Lai","year":"2007","unstructured":"Lai NM, Sivalingam N, Ramesh JC. Medical students in their final six months of training: progress in self-perceived clinical competence, and relationship between experience and confidence in practical skills. Singapore Med J. 2007;48:1018\u201327.","journal-title":"Singapore Med J"},{"key":"2222_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, et al. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1\u201313. https:\/\/doi.org\/10.1177\/1609406917733847.","journal-title":"Int J Qual Methods"},{"key":"2222_CR28","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s11096-021-01276-5","volume":"43","author":"P Forsyth","year":"2021","unstructured":"Forsyth P, Rushworth GF. Advanced pharmacist practice: where is the United Kingdom in pursuit of this \u2018Brave New World\u2019? Int J Clin Pharm. 2021;43:1426\u201330.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR29","unstructured":"Julian S, Morris J, Scobie S. Independent prescribing in the UK: workforce ambitions and implementation challenges. London: Nuffield Trust; 2026. Available at: https:\/\/www.nuffieldtrust.org.uk\/research\/independent-prescribing-in-the-uk-workforce-ambitions-and-implementation-challenges. Accessed 9 Apr 2026."},{"issue":"6","key":"2222_CR30","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s11096-022-01484-7","volume":"44","author":"GF Rushworth","year":"2022","unstructured":"Rushworth GF, Jebara T, Tonna AP, et al. General practice pharmacists\u2019 implementation of advanced clinical assessment skills: a qualitative study of behavioural determinants. Int J Clin Pharm. 2022;44(6):1417\u201324.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR31","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1007\/s11096-021-01296-1","volume":"43","author":"D Stewart","year":"2021","unstructured":"Stewart D, Pallivalapila A, Thomas B, et al. A theoretically informed, mixed-methods study of pharmacists\u2019 aspirations and readiness to implement pharmacist prescribing. Int J Clin Pharm. 2021;43:1638\u201350. https:\/\/doi.org\/10.1007\/s11096-021-01296-1.","journal-title":"Int J Clin Pharm"},{"key":"2222_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.sapharm.2017.06.007","volume":"14","author":"J Fisher","year":"2018","unstructured":"Fisher J, Kinnear M, Reid F, et al. What supports hospital pharmacist prescribing in Scotland? A mixed methods exploratory sequential study. Res Social Adm Pharm. 2018;14:488\u201397.","journal-title":"Res Social Adm Pharm"},{"key":"2222_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048171","volume":"11","author":"C Evans","year":"2021","unstructured":"Evans C, Poku B, Pearce R, et al. Characterising the outcomes, impacts and implementation challenges of advanced clinical practice roles in the UK: a scoping review. BMJ Open. 2021;11:e048171. https:\/\/doi.org\/10.1136\/bmjopen-2020-048171.","journal-title":"BMJ Open"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02222-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02222-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02222-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:38Z","timestamp":1793695178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02222-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2222"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02222-z","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared that they have no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics review was conducted by the Strathclyde Institute of Pharmacy and Biomedical Sciences Ethics Committee, University of Strathclyde. Ethical approval was granted for Stage 1 on 29 October 2024 and for Stage 2 on 13 May 2025. NHS Research Ethics Committee approval was not required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Electronic informed consent was obtained from all participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}